Literature DB >> 16945212

Cardiovascular disease and risk of Alzheimer's disease.

Caterina Rosano1, Anne B Newman.   

Abstract

Several recent studies demonstrate associations between cardiovascular disease and its risk factors and the incidence of Alzheimer's disease. This review will examine the evidence for these associations and possible pathogenetic pathways. Clinical relevance and implications of these associations will also be discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16945212     DOI: 10.1179/016164106X130407

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  20 in total

1.  Cardiovascular risk and memory in non-demented elderly women.

Authors:  Sophia Wang; Diane Jacobs; Howard Andrews; Wei-Yann Tsai; Xiaodong Luo; Christine Bergmann; Mary Sano
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

Review 2.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

Review 3.  A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review.

Authors:  Dana R Jorgensen; C Elizabeth Shaaban; Clayton A Wiley; Peter J Gianaros; Joseph Mettenburg; Caterina Rosano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-02       Impact factor: 4.733

4.  Associations Between Midlife (but Not Late-Life) Elevated Coronary Heart Disease Risk and Lower Cognitive Performance: Results From the Framingham Offspring Study.

Authors:  Nicole M Armstrong; Katherine J Bangen; Rhoda Au; Alden L Gross
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

5.  Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.

Authors:  Ji Zhang; Suqing Wang; Wei Huang; David A Bennett; Dennis W Dickson; Dengshun Wang; Rui Wang
Journal:  Mol Neurobiol       Date:  2015-09-19       Impact factor: 5.590

6.  Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.

Authors:  Ji Zhang; Yi-Rong Ding; Rui Wang
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

7.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  The type A behavior pattern and cardiovascular disease as predictors of dementia.

Authors:  Kathleen Bokenberger; Nancy L Pedersen; Margaret Gatz; Anna K Dahl
Journal:  Health Psychol       Date:  2013-12-23       Impact factor: 4.267

9.  Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases.

Authors:  Geidy E Serrano; Anthony Intorcia; Jeremiah Carew; Glenn Chiarolanza; Jose A Hidalgo; Lucia I Sue; Brittany N Dugger; Megan Saxon-LaBelle; Jessica Filon; Alex Scroggins; Joel Pullen; Brandon E Fornwalt; Sarah Scott; Marwan N Sabbagh; Charles H Adler; Haruhiko Akiyama; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

10.  Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.

Authors:  Ling Zheng; Wendy J Mack; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; T Scott Stroup; David L Sultzer; Pierre N Tariot; Cheryl Vigen; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2009-04-15       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.